Bioquell Regulatory News (BQE)

9 January, 2018

Bioquell PLC

Trading statement

Bioquell PLC ("Bioquell") (LSE symbol: BQE) - a leading provider of specialist biodecontamination products and services for the international Life Sciences, pharmaceutical and healthcare markets today announces an update on its trading performance prior to entering the closed period ahead of the preliminary results for the year to 31 December 2017.

We estimate that revenues for the year ended 31 December, 2017 will be ahead of our previous expectations at approximately £29.3 million (2016: £26.8 million)

This estimate comprises £28.6m for the biodecontamination business (2016: £25.2m), representing growth of some 13% (9.6% at constant currency rates) and £0.7m for the defence business (2016: £1.3m), where revenues fluctuate significantly from year to year.

Pre-exceptional earnings before tax are expected to be significantly ahead of market expectations. As previously announced, an exceptional gain of £0.25m will be recognised on the disposal of the Airflow business.

The Company had net cash of £14.5m at the year end.

The preliminary results for the year ended 31 December, 2017 will be announced on 7 March, 2018.

- Ends -

Enquiries

Bioquell PLC 01264 835900

Ian Johnson Executive Chairman

Michael Roller Finance Director